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Abstract
Background: Adverse drug events (ADEs) are a major source of morbidity and mortality, estimated as the forth to
sixth cause of annual deaths in the USA. Spontaneous reporting of suspected ADEs by health care professionals to
a national pharmacovigilance system is recognized as a useful method to detect and reduce harm from medicines;
however, underreporting is a major drawback. Understanding the barriers to ADE reporting and thereafter design of
interventions to increase ADE reporting requires a systematic approach and use of theory. Since multiple theories in
behavior change exist that may have conceptually overlapping constructs, a group of experts suggested an
integrative framework called theoretical domains framework (TDF). This approach considers a set of 12 domains,
came from 33 theories and 128 constructs, covering the main factors influencing practitioner behavior and barriers
to behavior change. The aim of this study is to apply TDF approach to establish an evidence-based understanding
of barriers associated with ADE reporting among nurses and pharmacists.
Methods: A total of three focus group discussions were conducted; among them two consisted of nurses and one
involved pharmacists. Discussions were guided by questions designed based on TDF. Transcriptions of discussions were
then thematically analyzed, and detected barriers to reporting ADEs were categorized based on extracted themes.
Results: A total of 34 nurses and pharmacists attended the group discussions. Six domains were identified to be relevant
to barriers of ADE reporting in hospitals. These domains included “Knowledge,” “Skills,” “Beliefs about consequences,”
“Motivation and goals (intention),” “Social influences (norms),” and “Environmental constraints.” We detected several
barriers to ADE reporting, such as lack of knowledge of what should be reported, fear of punishment and criticism, lack of
time, lack of teamwork, and lack of active support by hospital managements and other colleagues.
Based on detected barriers, “Cognitive and behavioral factors,” “Motivational factors and teamwork,” in addition to
“Organizational processes and resources” could be targeted in designing appropriate interventions.
Conclusions: Detection of barriers to reporting ADEs is necessary to design appropriate interventions. The TDF is a
comprehensive approach that enables us to better understand barriers to behavior change in reporting ADEs.
Background
Adverse drug events (ADEs) are major source of morbidity
and mortality and represent a significant patient safety con-
cern. According to World Health Organization (WHO)
definition, ADE is “any untoward medical occurrence that
may present during treatment with a pharmaceutical
product but which does not necessarily have a causal rela-
tionship with this treatment” [1]. ADEs may involve adverse
drug reactions (ADRs) and medication errors (MEs). ADR
is “a response which is noxious and unintended, and which
occurs at doses normally used in humans for the prophy-
laxis, diagnosis, or therapy of disease, or for the modifica-
tion of physiological function” [1].
ME is “any preventable event that may cause or lead
to inappropriate medication use or patient harm while
the medication is in the control of the health care pro-
fessional, patient, or consumer. Such events may be re-
lated to professional practice, health care products,
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procedures, and systems, including prescribing, order
communication, product labeling, packaging, nomen-
clature, compounding, dispensing, distribution, admin-
istration, education, monitoring, and use” [2].
It has been estimated that ADEs are the forth to sixth
leading cause of death in the USA [3]. Studies have shown
that hospitalized patients are at considerable risk for ex-
periencing ADEs, for example, a large meta-analysis of 39
prospective studies from US hospitals estimates that ADEs
accounted for 4.6 % of all fatalities [4]. A study conducted
in a Swedish population reported that 6.4 % of all fatalities
in hospitals were related to ADRs [5].
Pharmacovigilance is “the science and activities re-
lating to the detection, assessment, understanding and
prevention of adverse effects or any other drug-related
problem” [1]. Spontaneous reporting, as the backbone
of pharmacovigilance, is “a system whereby case re-
ports of ADEs are voluntarily submitted from health
professionals and pharmaceutical manufacturers to
the national regulatory authority” [1]. This method of
reporting ADEs has been used for years by many na-
tional pharmacovigilance centers in the world, as a
useful means for timely detection of ADEs in order to
minimize drug-related morbidity and mortality [6].
Pharmacovigilance activities in Iran
Iranian Pharmacovigilance Center (IPC) established spon-
taneous reporting system for collecting suspected ADEs in
1998 [7]. The ADE reports are submitted to IPC by health
care professionals, from all over the country, through de-
signed yellow cards. These reports include both ADRs and
MEs. In order to improve hospital reporting of ADEs, IPC
issued a guideline to all hospitals in the country. Accord-
ing to this guideline, each hospital designated a person
(physician, nurse, or pharmacist) as drug safety officer
(DSO). These DSOs from more than 600 hospitals were
then trained by IPC. Based on the guideline, hospital staffs
are free to report ADEs through DSOs or directly to IPC.
As a full member of WHO International Drug Monitor-
ing Program, IPC has now collected more than 35,000
reports of ADEs from all around the country. However, like
many other national centers in the world, it faces underre-
porting as a major drawback of spontaneous reporting [8].
It is estimated that only 2–4 % of all ADEs and 10 % of ser-
ious ones are reported [9]. Underreporting threatens drug
safety due to delay in detecting drug-related problems,
making it difficult to evaluate benefit-risk balance of medi-
cines. Studies have explained many reasons for underre-
porting, including fear of litigation, lack of knowledge (on
what and how to report), lack of confidence about drug-
reaction relationship, lack of interest, lack of time, wrong
beliefs (e.g., all approved medicines for marketing are safe),
and unavailability of yellow card [10]. Other studies added
attitude and motivational factors to the above list [11].
However, there are limited studies that have evaluated bar-
riers for reporting ADEs based on theories of behavior
change [12].
Understanding the barriers to ADE reporting based on
theoretical domains framework
Although health care can be improved at different levels
of the health system, one important intervention is to
support individual health professionals to modify their
behavior based on evidence [13]. The behavior evaluated
to be modified in this study is reporting ADEs. A thor-
ough understanding of the barriers of this behavior is an
important first step in the development of strategies to
address the barriers which may lead to effective inter-
ventions and increasing reporting and consequently re-
ducing ADEs and improving patient safety.
Understanding the barriers to ADE reporting and
thereafter design of interventions requires a systematic
approach and use of theory [14, 15]. With a better theor-
etical understanding of healthcare professional behav-
iors, the likelihood of success of interventions to change
behavior may be elevated. Theory can be used to under-
stand the factors and barriers that might influence the
targeted behavior change, to identify possible techniques
that could be utilized to change clinical behavior [16],
and to clarify how such techniques might work [17]. But
multiple theories and frameworks of individual and
organizational behavior change exist, and often these the-
ories have conceptually overlapping constructs [13, 18]. In
addition, only a few of these theories have been tested in
robust research in healthcare settings. There needs to be a
systematic approach for determining the relevant theories
(from all available theories) which predict behavior or
behavior change most comprehensively [19, 20].
Thus, theory selection needs to be based on a compre-
hensive theoretical assessment of the targeted behavior,
otherwise we run the risk of (1) missing relevant theoret-
ical constructs or including the irrelevant ones and (2)
designing interventions based on theories with overlap-
ping theoretical constructs [17, 21, 22]. This would make
identifying the specific processes involved in behavior
change very difficult.
As a solution to these problems, a group of experts,
including psychological theorists, health psychologists,
and health service researchers, came up with an inte-
grative framework called theoretical domains frame-
work (TDF) [16]. These experts identified psychological
and organizational theories relevant to health profes-
sional behavior change. Then they came up with a set
of 12 domains covering the main factors influencing
practitioner behavior and barriers to behavior change
which included: Knowledge; Skills; Social/professional
role and identity; Beliefs about capabilities; Beliefs about
consequences; Motivation and goals; Memory, attention,
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and decision processes; Environmental context and re-
sources; Social influences (norms); Emotion; Behavioral
regulation; and Nature of the behaviors. Since these theor-
etical domains came from 33 theories and 128 constructs
that explain health-related behavior change, they may
result in thorough understanding of the targeted behavior,
its barriers, and consequently comprehensive intervention
programs.
TDF has extensively been used to identify barriers to
change in healthcare in order to develop interventions
[21, 23–30]. Examples of these studies include investiga-
tion of the barriers and levers to hand hygiene [24] and
assessment of theoretical domains relevant to blood
transfusion practice in different contexts [25]. Also in
Australia, TDF has been used to identify the barriers
to the implementation of evidence-based guidelines
for acute low back pain [23, 31] and develop theory-
informed behavior change interventions [17]. Furthermore,
in Denmark, it has been used to enhance implementation
of tobacco use prevention and counseling guidelines among
dental providers [27].
The aim of the current study is to apply a broad com-
prehensive theory-based approach (utilizing TDF) to es-
tablish an evidence-based understanding of the processes
and barriers associated with ADE reporting among nurses
and pharmacists. Therefore, theoretical domains that
should be considered by an effective intervention program
to improve ADE reporting were identified. The result of
this study, when used to design tailored interventions in
improving ADE reporting, could also add to the science of
implementation research.
Methods
Study participants and design
This is a qualitative study based on focus group discus-
sions (FGDs). The IPC list of DSOs in Tehran hospitals
was used as the sampling frame for sample selection.
There were 117 DSOs from 117 hospitals in Tehran,
among them 60 were nurses, 51 pharmacists, and 6 phy-
sicians. Nurses reported most ADEs of the total regis-
tered cases in IPC database, followed by pharmacists
and physicians. During a 2-year period, IPC had received
3674 ADE reports sent by nurses, followed by 750 re-
ports by pharmacists, and 327 reports by physicians, so
we selected nurses and pharmacists as the groups of
choice to evaluate their opinion about barriers to ADE
reporting. We excluded hospitals in which physicians
were DSO since there were limited ADE reports received
from those hospitals. Then we first classified the remain-
der 111 hospitals by the job of DSOs (i.e., nurses or
pharmacists), then by type of hospital (private or public),
ADE reporting rate (good or weak reporting hospitals
based on IPC database), size of the hospital (small or
large hospitals based on number of beds), and hospitals
from both affluent and disadvantaged areas of the city.
We selected 45 DSOs that at least one person from each
hospital group was selected to be included in each FGD.
The selected DSOs were invited to participate in FGDs.
A total of 3 FGDs were conducted in summer of 2013,
among them 2 consisted of nurses (30 persons) and 1 in-
volved just pharmacists (15 persons). In order to get
broad information about barriers to ADE reporting, we
invited both DSO and non-DSO nurses to participate in
the two FGDs. But pharmacists were all DSOs since IPC
had not received considerable number of reports from
those who were not DSO. Informed consent was ob-
tained from all FGD participants.
In order to ensure consistency, the same facilitators
conducted the FGDs. A pharmacist expert in pharma-
covigilance along with a medical sociologist and an
epidemiologist expert in knowledge translation and ex-
change (KTE) conducted all FGDs. Each session was
about 90 min. The discussions were recorded, and one
of the facilitators took notes in the sessions.
Discussion questions
A set of questions was designed based on 12 different
domains of TDF developed by Michie et al. [16]. The
discussion questions were first piloted in two different
interviews and revised based on the results. The final
version of the questions was discussed in focus groups.
During and at the end of discussions, FGD participants
were asked to add more comments on discussed ques-
tions or domains. They were free to add these additional
points during FGD or to contact the research group later
via phone or email.
Data analysis
A verbatim transcript of each FGD was prepared from
the tape recording of the sessions. Transcription of all
audio tapes was done externally (by a paid company),
and one of the authors (GS) reviewed them for accuracy
and completeness. To maintain anonymity, names of
people and hospitals were removed from transcripts.
Two of the researchers read all three FGD transcripts
multiple times, on their own. They coded the transcripts
based on the 12 domains of TDF and performed the-
matic analysis. Both inductive and deductive approaches
were used to make sure no theme was missed. Specific
themes were extracted and then categorized according
to 12 domains of TDF, with their related subthemes. To
assess agreement between two researchers, all extracted
themes and subthemes were reviewed in a meeting. The
two researchers had high agreement (>90 %). Disagree-
ments were discussed and a final theme or subtheme
was chosen.
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Ethics
The study has been approved by the Institutional Review
Board of Tehran University of Medical Science which
follows the Helsinki Declaration.
Results
Among 45 invited persons, 34 nurses and pharmacists
attended the FGDs. Statistics on how many nurses and
pharmacists attended FGDs can be found in Table 1. Based
on FGDs, we excluded domains that involved irrelevant
themes. Also, whenever we identified overlapping in de-
tected themes in different domains, we excluded irrelevant
domains. We discovered the same themes using inductive
and deductive approaches, so we did not report them sep-
arately. A total of six domains were identified to be relevant
to barriers and facilitators of ADE reporting in hospitals.
These domains included Knowledge, Skills, Beliefs about
consequences (anticipated outcomes/attitude), Motivation
and goals (intention), Environmental context and resources
(environmental constraints), and Social influences (norms).
We have discussed the details of the method for selection
of domains elsewhere (paper in progress). Sixteen different
themes were extracted from transcripts of FGDs. The iden-
tified themes across relevant domains, and related ques-
tions, are demonstrated in Table 2.
Knowledge
Most nurses and pharmacists were aware of ADE report-
ing process in their hospitals; however, they were not
well informed of reporting guidelines on ADE reporting.
They could not provide a comprehensive definition of
ADE, ADR, or ME in accordance with the national
guideline for reporting ADEs. Here are some of the defi-
nitions they offered:
“ADRs are related to the medication but MEs are
errors in administration of the medication”
“MEs are not part of ADEs.”
Nurses and pharmacists in all three FGDs stated that ser-
ious ADEs, in addition to cutaneous ADEs, were more fre-
quently reported in their hospitals compared to other types
of ADEs. They also mentioned that MEs which resulted in
patient harm were mostly reported. Most focus group par-
ticipants believed that ADEs which were common, certain,
known, or preventable should be reported. However, there
was some controversy in reporting common and routine
ADEs. Here are some of their comments:
“We only report common ADEs and those that are
mentioned in the brochures.”
“If we report all ADEs, physicians will seriously be
limited [in prescribing medicine].”
“We do not report routine ADEs otherwise we have
to spend most of our time filling up forms [to report
ADEs].”
Skills
Nurses and pharmacists who participated in the focus
groups did not feel reporting ADEs was difficult to do.
However, nurses found reporting ADRs less controver-
sial than reporting MEs.
Participants, in general, were not able to differentiate
between ADR and ME in practice:
“MEs are errors in drug use which do not lead to
patient harm.”
“MEs happen before drug consumption while ADRs
occur after using medication.”
Beliefs about consequences (anticipated outcomes/
attitude)
In general, focus group participants expected many positive
consequences by reporting ADEs. The most reported posi-
tive outcomes of ADE reporting included the following:
reducing drug-related morbidity and mortality, increasing
scientific knowledge of health professionals, improving
quality of medicines, decreasing therapeutic cost, shorten-
ing hospital stay, replacing problematic drugs with safer
alternatives, detecting counterfeit medicines, improving
pharmacotherapy, preventing ADEs in other patients, redu-
cing overuse of medicines, identifying precautions for drug
use, preventing drug interactions, and improving patient
safety. Some of the participants’ comments are listed below:
“A good example is the problems we encountered
following injection of ceftriaxone. When we became
familiar with its adverse reactions, we realized that we
should be more careful.”
“In my opinion, the most important consequence is
that we can identify problems in manufacturing
medicinal products.”
Table 1 Statistics on how many nurses and pharmacists attended FGDs
Focus group Participants occupation Number of invited persons Number of attendees
First FGD DSO nurses 15 12
Second FGD DSO pharmacists 15 10
Third FGD Non-DSO nurses 15 12
Mirbaha et al. Implementation Science  (2015) 10:110 Page 4 of 10
On the other hand, a few participants pointed out the
following negative consequences: punishment of individ-
uals involved in occurring ADE or recall of a beneficial
medicine from the market by mistake. Here are some
examples of the participants’ comments:
“If what is reported is not a real ADE, the suspected
medicine may be recalled by mistake.”
“There may not be negative consequences for us but
the manufacturers may incur some unjustified
expenses.”
Motivation and goals (intention)
Most nurses and pharmacists in the focus groups re-
ported that they were motivated to report ADEs. That
was an expected result since most participants were
DSOs. However, there were few individuals who men-
tioned that they might not choose to report because of
lack of feedback from the pharmacovigilance center.
They thought it was just a waste of time since they did
not see a positive effect from their reporting. Here is an
example comment:
“The problem is that we report ADEs but do not get
any feedback.”
Some FGD participants referred to lack of motivation
for reporting ADEs in nursing staff except for DSOs,
especially the young generation. In addition, fear of criti-
cism and punishment was suggested as a barrier to
reporting ADEs by nursing staff. Some of the comments
in this domain were as follows:
“If nurses think that we [the supervisors] will criticize
them, they won’t report.”
“The young generation is more relaxed and a bit lazy.
They are not well educated in ethical concerns and
they are not patient enough to fill in yellow cards.”
“They [young nurses] don’t seem to be motivated.”
“A young nurse fresh out of college to tell me [the
supervisor] that I should do the job for the patient
myself, in my opinion, they need ethical training.
They don’t give the patient their medication and when
questioned they say that they were out of that
medicine!”
“If nurses were not under pressure of their
supervisors to report, they would not report ADRs.”
Some participants believed that new activities related
to hospital accreditation took a lot of their time and
made them not want to take on any other responsibility
such as ADE reporting. One participant commented the
following:
“Another reason is that hospital staff has been urged
to do lots of new activities in a short period of time
Table 2 Questions related to different domains and identified themes
Domain Questions Themes
Knowledge What do you know about ADE reporting system in the country? Awareness of ADE reporting system
How do you define ADR? Awareness of ADE reporting guideline
How do you define ME? Awareness of what should be reported
Awareness of ADE definitions
Skills What is the difference between ADR and ME? Distinguish between ADR and ME
Is reporting ADEs difficult for you? Reporting difficulty




Motivation and goals How motivated are you to report ADEs? Motivation to report
What are the incentives in reporting ADEs? Incentives
Do you regularly have other activities or goals that might interfere
with your reporting ADEs?
Interference with other goals and activities
Environmental context and
resources
To what extent do physical factors or resources facilitate or hinder
your reporting ADEs?
The impact of physical factors or resources on
reporting ADEs
How does time constraint impact your reporting ADEs? Time constraint
Social influences (norms) Are ADEs actively reported by other health professionals in your
hospital?
ADE reporting by other hospital staff
Do hospital managers and your colleagues approve your reporting
ADEs?
Reporting approval by hospital managers and
colleagues
Is there anyone who disapproves or opposes your reporting ADEs in
your hospital?
Disapproval of ADE reporting
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and everyday something is added to the list so nurses
are all involved in this issue and show resistance to
take on any additional activity. When they are asked
to do a minute thing, they react by saying that they
are exhausted. I think hospital accreditation staff has a
lot to do with it.”
Many FGD attendees outlined incentives as a major
factor in reporting ADEs. Only a handful of hospitals
currently seemed to have incentives for ADE reporting
such as gift certificates. Interestingly, the majority of
hospitals offered incentives for internal reporting of
MEs. Here are some of the comments in this regard:
“We should always encourage ADR reporting, even a
nurse should understand that potential bonuses is due
to her ADR reporting”
“The [pharmacovigilance] center should send a letter
to say thank you for your efforts.”
“Those with lots of ADE reporting [in her hospital]
receive incentives from the head nurse.”
“I have seen that nurses committed some MEs, they
reported their own errors and have been praised for
doing that and received incentives.”
Environmental context and resources (environmental
constraints)
A major concern outlined by nurses and pharmacists was
lack of time for reporting ADEs. A number of nurses
pointed out that completing yellow cards for ADE report-
ing took a long time. Other mentioned barriers were
complicated and time-consuming administrative proce-
dures in reporting process and limited access to appropri-
ate equipment and resources for submitting ADE reports.
Lack of adequate human resources and fast turnover rate
of nurses were other mentioned hampering factors. They
mentioned that fast turnover rate of nurses led to missed
trained nurses, and they had to repeat educational pro-
grams on ADE reporting from the beginning. Here are
some examples of the comments:
“When two nurses are in charge of 30 patients, they
really don’t have time to do such things [report
ADEs]. I, myself, observe ten cases of ADE but don’t
have time to report even one case. I report them all
once and say for example that ten patients have
developed same ADE following consumption of a
particular medicine, because I have no time to fill in a
separate yellow card for each patient.”
“Sometimes it takes half an hour just to fax a yellow
card to ADR Center.”
Participants in all three FGDs suggested that involve-
ment of clinical pharmacists who, in their opinion, were
experts in recognizing ADEs could really benefit ADE
reporting in hospitals. They also stated that easy access
to yellow cards could facilitate ADE reporting.
Social influences (norms)
FGD participants believed that good social relations
among supervisors and nursing staff increased ADE
reporting. Here are some of the comments:
“If we [supervisors] present and explain the
requirements [for ADE reporting] appropriately, they
[the staff] will collaborate with us.”
“Not everybody wants to get involved; it really
depends on type of interaction between staff and
supervisors.”
One of the major barriers for ADE reporting, to them,
was lack of collaboration between nurses, pharmacists
and physicians. They named teamwork an essential com-
ponent of ADE reporting.
All three focus groups reported that hospital executive
administrators approved ADE reporting; however, they
did not do anything to facilitate it. There were no incen-
tives or punishment systems in place to improve ADE
reporting. Supervisors and other health care profes-
sionals in their hospitals also approved ADE reporting
while they might not play an active role. Here is one of
the comments:
“Hospital top management surely approves ADE
reporting; however they do not get involved. There
are no incentives or punishments in regard to
reporting in place.”
Generally, nurses and pharmacists in the focus groups
stated that there were no individuals or groups of people
who really opposed ADE reporting in hospitals. How-
ever, some nurses were not motivated enough to report
ADEs. They accounted fear of punishment and limited
time for completing ADE-reporting procedure as rea-
sons for lack of motivation in ADE reporting. These un-
motivated nurses did not agree with ADE reporting in
hospitals. Below some of these comments are listed:
“Nobody openly announces that they are against
reporting, although there are some nurses who are
not enough motivated.”
“A few times, even the completed yellow card was not
sent [by nurses because of lack of motivation], I
[DSO] had to follow it up.”
Discussion
We identified several barriers to reporting ADEs in this
study. Identified barriers in each detected domain are
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shown in Table 3. Also, examples of suggested interven-
tions to remove these barriers are listed in the same
table [32].
In the category of “Knowledge” domain, the results of
this study revealed that there was low awareness of what
should be reported among nurses and pharmacists in
the studied hospitals. According to many of the study
participants, ADEs should be reported when they are
common, certain, known, or preventable. This finding is
in accordance with other studies [33–35]. Participants’
lack of awareness about reporting requirements was
partly due to their unfamiliarity with the guidelines. In-
terventions should focus on special education and train-
ing, including the published guidelines, since they can
find necessary information on what and how ADEs
should be reported. We found that all participants were
aware of the pharmacovigilance system in the country.
This is in contrast with studies that discovered that not
all hospital physicians and nurses had enough knowledge
of the existence of ADE reporting system in their coun-
try [33, 35]. Cognitive and behavioral factors should be
targeted in designing appropriate interventions for this
level of barriers such as those suggested in Table 3.
With regard to “Skills” domain, according to study
participants, nurses and pharmacists did know how to
report ADRs and found it fairly easy to do. However,
reporting MEs was not as easy for nurses. This formed
another barrier for reporting as lack of skills in differ-
entiating ADRs and MEs so that nurses moved towards
non-reporting of MEs to IPC. We discovered that
nurses were somewhat uneasy about reporting MEs if
they felt that confidentiality with reporter identity was
not respected. Confidentiality with patients’ data has
been identified as a matter of importance in another
study conducted in a Spanish tertiary teaching hospital
[10]. Providing education such as workshops to im-
prove nurses’ skills in reporting MEs is suggested as an
appropriate intervention.
In the “Beliefs about consequences” domain, problems
of legal liability and possible judicial claims were de-
tected as a potential obstacle to reporting ADRs in
Spanish study [10]. However, we found fear of punish-
ment and litigation of reporter or hospital staff involved
in occurring ADE as a major barrier for reporting ADEs.
The respondents perceived this barrier as a probable
negative outcome of ADE reporting. Another problem
was that they were trained to report MEs internally and
excluded them from reporting to IPC. We found that
there is a need to educate nurses and pharmacists that
there is no punishment for reporters, and reporter iden-
tity is confidential.
As a motivational factor, we concluded that incentives
may have a considerable impact on increasing ADE
reporting in hospitals. This factor has been discussed in
Table 3 Identified barriers and examples of appropriate interventions in different domains
Domain Identified barriers Example of appropriate interventions [32]
Knowledge Lack of knowledge of what should be reported Information delivery methods adopted to individual needs
Lack of knowledge of definitions
Lack of knowledge of guideline
Skills Lack of skills in differentiating ADRs and MEs Provide education to improve competency
Beliefs about
consequences
Fear of punishment and criticism Provide education on consequences
Motivation and goals Lack of feedback Provide more feedback such as timely alerts
Lack of motivation Provide information about impact of reporting, social influence (e.g.,
provide a role model)
Heavy workload Training on time management, provide help
Lack of incentives Provide appropriate incentives
Environmental
constraints
Lack of sufficient human resources Establish specific department for drug safety
Lack of sufficient time for reporting Revise reporting procedures
Complicated yellow card Revise and redesign yellow card
Complicated administrative reporting procedure Redesign reporting procedure
Lack of reporting facilities Provide appropriate facilities
Lack of clinical pharmacist Recruit and train clinical pharmacist
No access to yellow cards Easy access to yellow cards
Social influences Lack of teamwork Training to change group processes
Lack of active support by hospital management and
other colleagues
Organize social influence (provide support )
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other studies [36–38]. These studies have shown that fi-
nancial incentives could have positive consequences and
may lead to increased reports of ADEs. However, as sug-
gested by our study participants, nonfinancial incentives
could also be offered. Consequently, interventions to
promote ADE reporting should include well-defined
incentives for those who report ADEs, provided by dif-
ferent levels of health system management (e.g., hospital
management, IPC, etc.). For example, drug safety annual
award for high-quality ADE reporting can be considered.
By detecting lack of teamwork as a “Social influences
(norm)”-related barrier, the results of our study indicated
that interventions that target teamwork are also neces-
sary to improve ADE reporting. Nurses reported very
low level of collaboration with physicians and pharma-
cists in reporting ADEs. They mentioned that they did
not have enough collaboration of physicians in diagnosis
or confirmation of ADEs. Similarly, they complained of
lack of collaboration of pharmacists in sharing informa-
tion on side effects of drugs or their medicinal consult-
ation. A possible solution to this obstacle is to improve
participation of pharmacists in detecting and reporting
ADEs. We conclude that reporting ADEs in hospitals
needs a strong team and teamwork in which responsibil-
ities of each member of the group is well defined. This
finding was new to us since we did not find similar find-
ings in other studies.
Lack of active support by hospital managements and
other colleagues was another barrier detected in “Social
influences (norms)” domain. The results of this study
showed that reporting ADEs was socially influenced by
culture of reporting in the hospital. Nurses did not have
role models among supervisors and higher management
and did not feel they were socially supported in their
hospitals for reporting ADEs. Hospital executives did
not have promotion of ADE reporting on their agenda
and did not seem to have different plans for the future.
The culture of reporting was not well established in the
hospitals, making it difficult for nurses to overcome per-
ceived drawbacks of reporting, such as confrontation
with supervisors and other colleagues. To overcome this
obstacle, interventions that target hospital managers
are helpful as they are at the top of the pyramid of
decision-making.
Barriers related to “Environmental constraints” includ-
ing lack of human resources as well as technical facilities
were identified as barriers to reporting ADEs in our
study. As an example for human resources, utilization of
additional clinical pharmacists as reporting facilitators
was suggested by the studied participants. Studies have
shown that the presence of a clinical pharmacist in a
hospital results in increased ADE reporting [39, 40].
Lack of reporting facilities and complicated administra-
tive procedures were noted as problematic to the ADE
reporting in this study. Participants declared that lack of
facilities such as easy access to fax, the availability and easy
access to yellow cards, and an internet-based reporting sys-
tem could have negative impact on ADE reporting. Consist-
ent with other studies [10, 41], lack of sufficient time was
identified in this study as a major barrier for ADE report-
ing. A comprehensive intervention should include time
management training and strategies such as revising
and shortening of reporting procedures. For instance,
yellow cards, as well as detailed administrative proced-
ure of reporting in hospitals, have to be reviewed for
necessary changes.
Limitations of the study
We faced some limitations in this study. The first one
was low rate of ADE reporting by physicians and non-
DSO pharmacists, and that was why they were not in-
cluded in FGDs.
Another limitation, as in any FGD, was that some par-
ticipants were more willing to speak and present their
ideas than others. As a result, some participants might
have refrained from presenting their opinions if others
had already stated similar ideas. In order to overcome
this limitation, at the end of each discussion topic, we
asked the participants, whether they agreed or disagreed
with the discussions.
There are numerous terms in the field of pharmacov-
igilance, each one involved special aspect of what should
be reported. This variety of terminology led to another
limitation in choosing appropriate terms for evaluating
participants’ knowledge about what should be reported.
As we mentioned above, ADR and ME are two elements
of ADEs. It was important to us to assess the ability of
participants to distinguish between these two words, so
we asked them to define ADR and ME, separately. The
answer to this question could reveal how study partici-
pants think about the concept of what should be re-
ported or the concept of ADE. So we preferred not to
confuse them by asking the definition of several words,
instead we asked about the components of ADE which
were ADR and ME.
Conclusions
Detection of barriers to reporting ADEs by nurses and
pharmacists is necessary to design appropriate interven-
tions. The main barriers detected in this study were re-
lated to six domains of Knowledge, Skills, Beliefs about
consequences, Motivation and goals, Environmental
constraints, and Social influences (norms). Some of the
detected barriers in this study were previously deter-
mined by other studies conducted in different settings,
such as lack of knowledge or skills in different aspects
of ADE reporting, fear of punishment and criticism,
and/or lack of time. However in this study, TDF helped
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us explore some barriers such as problems in team
working which was not identified in similar studies.
We believe that TDF is a comprehensive approach that
enables us to better understand and classify barriers to
behavior change in reporting ADEs. Classification of bar-
riers based on different psychological domains could be
effective in mapping suitable interventions to detected
barriers. Appropriate interventions should be tailored and
implemented based upon identified barriers in each of the
related domains.
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